Guo, W., Li, H., Lou, Y., Zhang, Y., Wang, J., Qian, M., . . . Xu, Y. (2021). Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation. J Orthop Translat.
Styl cytowania ChicagoGuo, Wen, Haijun Li, Yan Lou, Yue Zhang, Jia Wang, Ming Qian, Haifeng Wei, Jianru Xiao, i Youjia Xu. "Tyloxapol Inhibits RANKL-stimulated Osteoclastogenesis and Ovariectomized-induced Bone Loss By Restraining NF-κB and MAPK Activation." J Orthop Translat 2021.
Styl cytowania MLAGuo, Wen, et al. "Tyloxapol Inhibits RANKL-stimulated Osteoclastogenesis and Ovariectomized-induced Bone Loss By Restraining NF-κB and MAPK Activation." J Orthop Translat 2021.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..